CHIMERISM POST TRANSPLANT PROFILE

image not found

NABL Cap Accredited 

The Chimerism Post Transplant Profile measures the proportion of donor and recipient cells after a stem cell or bone marrow transplant. Metropolis Healthcare uses advanced STR-based molecular techniques to deliver precise and sensitive chimerism quantification. This profile is essential for monitoring engraftment, detecting graft failure, and identifying early relapse. Regular post-transplant testing helps clinicians make timely therapeutic adjustments.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 10,395.00

Sample Type: EDTA Blood

Fasting Not Required


Notes: C0307

Frequently Asked Questions (FAQ's):

What does the Chimerism Post Transplant Profile include?
This profile quantifies the percentage of donor and recipient cells to evaluate engraftment status and post-transplant recovery.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses PCR-based STR analysis with highly sensitive detection platforms to ensure accurate and reproducible chimerism measurements.

Who should take this test?
Patients who have undergone stem cell or bone marrow transplantation are routinely advised to undergo chimerism monitoring at scheduled intervals.

Why is post-transplant chimerism monitoring important?
Monitoring helps detect graft failure, mixed chimerism, early disease relapse, or rejection, allowing timely modification of treatment.

What sample type is required?
A peripheral blood sample is typically used, though bone marrow samples may be requested depending on clinical needs.

How reliable are results from Metropolis Healthcare?
Metropolis Healthcare follows stringent quality protocols, validated molecular systems, and expert interpretation to ensure high-accuracy results.

Is any preparation required before giving the sample?
No special preparation is needed; patients can provide the required sample as instructed by their transplant team.

How often should this test be performed?
Frequency is determined by the treating physician, but it is commonly performed at regular intervals during the post-transplant period to monitor recovery.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab